Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ijantimicag.2020.106009 http://scihub22266oqcxt.onion/10.1016/j.ijantimicag.2020.106009 32389721!7204657!32389721     free     free     free       Int+J+Antimicrob+Agents 2020 ; 56 (1): 106009 Nephropedia Template TP {{tp|p=32389721|t=2020. Tocilizumab in COVID-19: Beware the risk of intestinal perforation |pdf=|usr=}}{{32389721}} gab.com Text Tocilizumab in COVID-19: Beware the risk of intestinal perforation JO: Int J Antimicrob Agents http://www.kidney.de/pget.php?&tw=1&pmid=32389721 #FOAvip ? Twit Text FOAVip Tocilizumab in COVID-19: Beware the risk of intestinal perforation ????Int J Antimicrob Agents http://www.kidney.de/pget.php?&tw=1&pmid=32389721 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32389721 #FOAvip English Wikipedia <ref>{{Cite pmid|32389721}}</ref> Tocilizumab in COVID-19: Beware the risk of intestinal perforation #MMPMID32389721 Vikse J; Henry BM Int J Antimicrob Agents 2020[Jul]; 56 (1): 106009 PMID32389721show ga ? |*Betacoronavirus[MESH] |Angiotensin-Converting Enzyme 2[MESH] |Antibodies, Monoclonal, Humanized/*adverse effects[MESH] |COVID-19[MESH] |Coronavirus Infections/*drug therapy[MESH] |Humans[MESH] |Intestinal Perforation/*chemically induced[MESH] |Pandemics[MESH] |Peptidyl-Dipeptidase A/physiology[MESH] |Pneumonia, Viral/*drug therapy[MESH]Tocilizumab in COVID-19: Beware the risk of intestinal perforation (epmc).pdf DeepDyve Pubget Overpricing